HEYL and breast cancer: Based on the literature and our own observation of HEYL expression in both the tumor endothelial and epithelial cells, we proposed that of the downstream effectors of Notch, among the three members of the HEY family, HEYL may be the primary mediator of Notch pathway action to induce tumor angiogenesis in breast cancer.